Chemours Company is a global leader in chemistry and material science, specializing in the production of a diverse range of industrial solutions
The company focuses on developing innovative products in critical sectors such as advanced performance materials, fluoroproducts, and titanium technologies. Chemours plays a significant role in addressing environmental challenges, offering sustainable solutions that enhance performance while minimizing ecological impact. Their cutting-edge technologies cater to various industries, including electronics, automotive, construction, and manufacturing, aiming to drive progress and improve the quality of everyday life through their specialized chemical products.
GREENWICH, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20, 2025. The symposium will draw a variety of companies, with a focus on pricing power, margin recovery, interest rates, inventory stabilization, global trade policy, demand trends, and the M&A environment. Attendees will also have the opportunity to meet with managements in a one-on-one setting.
The Chemours Company (Chemours) (NYSECC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announces the launch of Ti-Pure™ TS-6706, a TMP- and TME- free version of Ti-Pure™ R-706 – the benchmark, universal titanium dioxide (TiO2) grade that works reliably for a variety of coatings applications where appearance is critical.
The Chemours Company (“Chemours” or “the Company”) (NYSECC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2024.
The Chemours Company (“Chemours”) (NYSECC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025.
The Chemours Company (Chemours) (NYSECC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. The Company also announced the date for its 2025 Annual Shareholders Meeting.
The Chemours Company (“Chemours” or “the Company”) (NYSECC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025.
Truist Securities analyst initiates coverage on chemicals stocks before earnings release. Companies include Chemours, Tronox, Minerals Tech, and Westlake.
The Chemours Company (NYSECC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours’ Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team.
The Chemours Company (Chemours) (NYSECC), a global leader in delivering innovative performance chemistry, today announced the appointment of Joseph (Joe) Kava to its Board of Directors, effective January 3, 2025.
The Chemours Company (Chemours) (NYSECC) today announced the successful repricing of its Tranche B-3 Euro denominated Term Loan under its senior secured term loan facility due in August 2028.
The Chemours Company (Chemours) (NYSECC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide (TiO2) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize state-of-the-art technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant being operational in 2028.
The Chemours Company (Chemours) (NYSECC) today announced the successful repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan under its senior secured term loan facility due in August 2028.
